710 related articles for article (PubMed ID: 12874259)
1. CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo.
Oldenhove G; de Heusch M; Urbain-Vansanten G; Urbain J; Maliszewski C; Leo O; Moser M
J Exp Med; 2003 Jul; 198(2):259-66. PubMed ID: 12874259
[TBL] [Abstract][Full Text] [Related]
2. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
3. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
4. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
Chen X; Oppenheim JJ; Howard OM
J Leukoc Biol; 2005 Jul; 78(1):114-21. PubMed ID: 15845645
[TBL] [Abstract][Full Text] [Related]
5. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
George TC; Bilsborough J; Viney JL; Norment AM
Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
[TBL] [Abstract][Full Text] [Related]
6. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
7. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
[TBL] [Abstract][Full Text] [Related]
8. Persistence of apoptosis-resistant T cell-activating dendritic cells promotes T helper type-2 response and IgE antibody production.
Arques JL; Regoli M; Bertelli E; Nicoletti C
Mol Immunol; 2008 Apr; 45(8):2177-86. PubMed ID: 18237782
[TBL] [Abstract][Full Text] [Related]
9. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
11. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
Yang AS; Lattime EC
Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
[TBL] [Abstract][Full Text] [Related]
13. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
Sugimoto A; Suzuki M; Otani T; Okochi A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2009 Dec; 37(12):1454-63. PubMed ID: 19819295
[TBL] [Abstract][Full Text] [Related]
14. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
16. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
17. Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells.
Wiegard C; Frenzel C; Herkel J; Kallen KJ; Schmitt E; Lohse AW
Hepatology; 2005 Jul; 42(1):193-9. PubMed ID: 15962311
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
[TBL] [Abstract][Full Text] [Related]
19. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.
Mascarell L; Lombardi V; Louise A; Saint-Lu N; Chabre H; Moussu H; Betbeder D; Balazuc AM; Van Overtvelt L; Moingeon P
J Allergy Clin Immunol; 2008 Sep; 122(3):603-9.e5. PubMed ID: 18774396
[TBL] [Abstract][Full Text] [Related]
20. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]